Sara
García Alonso
Investigadora en el període 2017-2019
Publicacions (11) Publicacions de Sara García Alonso
2022
-
KSR induces RAS-independent MAPK pathway activation and modulates the efficacy of KRAS inhibitors
Molecular Oncology, Vol. 16, Núm. 17, pp. 3066-3081
-
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
Molecular Cancer Research, Vol. 20, Núm. 7, pp. 1108-1121
2021
-
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma
Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1
-
RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression
Cancer Cell
2018
-
Refining Early Antitumoral Drug Development
Trends in Pharmacological Sciences
-
Resistance to antibody–drug conjugates
Cancer Research, Vol. 78, Núm. 9, pp. 2159-2165
2017
-
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer
Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019
-
Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity
Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651
2016
-
Multisite phosphorylation of P-Rex1 by protein kinase C
Oncotarget, Vol. 7, Núm. 47, pp. 77937-77949
2015
-
Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling
Oncotarget, Vol. 6, Núm. 30, pp. 30057-30071
-
P73 is required for endothelial cell differentiation, migration and the formation of vascular networks regulating VEGF and TGFβ signaling
Cell Death and Differentiation, Vol. 22, Núm. 8, pp. 1287-1299